ConocoPhillips filed disclosures with the SEC, while Morgan Stanley boosted its price target and Freedom Capital upgraded its rating.
1 report, 1 independent
Updated Wed 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ConocoPhillips filed disclosures with the SEC, while Morgan Stanley boosted its price target and Freedom Capital upgraded its rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
ConocoPhillips
American oil and gas company
-
Morgan Stanley
U.S. investment bank
-
Freedom Capital
company in the Czech Republic
Related events
- ConocoPhillips made required institutional filings with the SEC and reduced its price target on COP shares.
- Analyst ratings disclosed via SEC filing involving Morgan Stanley, Royal Bank of Canada, and the SEC.
- Morgan Stanley provided a new price target and insider transactions were disclosed to the SEC involving Manhattan Associates.
- Morgan Stanley and Royal Bank of Canada raised price targets for ConocoPhillips stock.
- Citigroup, Morgan Stanley, and TD Cowen have raised their price targets and upgraded ratings for Royalty Pharma, with filings made public via the SEC.